Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocksAJANTPHARM
resources
AJANTPHARM
3,283.90+13.3 (+0.41%)
23 Oct, 12:00 AM

Annual Reports and Financial Documents

Ajanta Pharma Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

Corporate Announcements and Regulatory Filings

Ajanta Pharma Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  1. Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 201121 Oct 2026
    Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
    The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on October 19, 2026 for Aayush Agrawal, trustee ....
  2. Analyst / Investor Meet15 Oct 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Pls find enclosed Earnings Conference Call Intimation.
  3. Board Meeting15 Oct 2026
    Board Meeting Intimation for Considering And Approving Unaudited Financial Results For Q2 FY 2027
    Ajanta Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2026 ,inter alia, to consider and approve Unaudited consolidated and standalone ....
  4. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20187 Oct 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Pls find enclosed Certificate as per Reg 74(5) of SEBI (DP) Regulations.
  5. Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 20116 Oct 2026
    Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
    The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on October 06, 2026 for Aayush Agrawal, trustee ....
  6. Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 20111 Oct 2026
    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for CTL Trusteeship Ltd
  7. General30 Sept 2026
    Submission Of Sustainability Report For FY 2026
    Pls find enclosed herewith Sustainability Report for FY 2026.
  8. Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 201128 Sept 2026
    Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
    The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 28, 2026 for Aayush Agrawal, ....
  9. Closure of Trading Window25 Sept 2026
    Closure of Trading Window
    Pls find enclosed herewith closure of trading window intimation
  10. Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 201118 Sept 2026
    Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
    The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 18, 2026 for Aayush Agrawal, ....
  11. General31 Aug 2026
    Participation In Investor Conference
    Pls find enclosed Intimation w.r.t Participation in Investor Conference.
  12. Newspaper Publication31 Aug 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Pls find enclosed newspaper publication for transfer of equity shares to IEPF.
  13. Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 201127 Aug 2026
    Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
    The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 27, 2026 for Aayush Agrawal, trustee ....
  14. Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 201119 Aug 2026
    Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
    The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 19, 2026 for Ravi Agrawal, trustee ....
  15. Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 201114 Aug 2026
    Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
    The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 14, 2026 for Ravi Agrawal, trustee ....
  16. General5 Aug 2026
    Participation In Investor Conference
    Pls find enclosed Intimation w.r.t participation in Investor Conference
  17. Newspaper Publication31 Jul 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Pls find enclosed newspaper publication of financial results for the quarter ended 30.06.2026.
  18. Analyst / Investor Meet30 Jul 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
    Pls find enclosed Audio Recording of Earnings Call
  19. Allotment of ESOP / ESPS30 Jul 2026
    Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
    Pls find enclosed ESOP Allotment
  20. Record Date30 Jul 2026
    Record Date Intimation For Dividend
    PFA record date intimation

Frequently Asked Questions

Where can I download the annual report of Ajanta Pharma Ltd.?
Annual reports of Ajanta Pharma Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Ajanta Pharma Ltd.?
Quarterly earnings results and presentations of Ajanta Pharma Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Ajanta Pharma Ltd. publish earnings call transcripts?
Earnings call transcripts of Ajanta Pharma Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Ajanta Pharma Ltd.?
Investor presentations and annual day presentations of Ajanta Pharma Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Ajanta Pharma Ltd.?
Corporate announcements and regulatory filings of Ajanta Pharma Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Ajanta Pharma Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Ajanta Pharma Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Ajanta Pharma Ltd.?
The ISIN (International Securities Identification Number) of Ajanta Pharma Ltd. is INE031B01049. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Ajanta Pharma Ltd. listed?
Ajanta Pharma Ltd. is listed on NSE and BSE. The NSE symbol is AJANTPHARM and the BSE code is -.
Where can I find the shareholding pattern of Ajanta Pharma Ltd.?
The quarterly shareholding pattern of Ajanta Pharma Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Ajanta Pharma Ltd. on Sharpely?
Share price data for Ajanta Pharma Ltd. is updated as of 23 Oct 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.